reference/12660919

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12660919

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Review
endingPage	661
issn	1750-7448 1750-743X
issueIdentifier	4
pageRange	645-661
publicationName	Immunotherapy
startingPage	645
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bd65ed37a7eb350d1e4404d1687f928 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ec34229d70eedcfa983f95021eacaef4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d3e816ea5d4b2a4892bae79d189b11ae http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ff1d1a94be57dce27ddc1e68bc225be4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_32996d0b89ad46687ff816835d2f867d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c71f1a355f8efcab9b913825db860f5c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a76ebbd4f2498685ea9b450f0b170b20 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_07936aed19f018a53d59f61d177c357b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7afa0ce58806c63d371abbfb81f18a5e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d8d1f5e34698c900975048814c307628 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7f0c19192648d06d81a354039e3db85d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_de59ce2fd44aab30fd2c4aa4a7f9d4ab http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cfd9bdc96922c36e671f0e83f3f039b6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b6a96299d61c3f96cdf01127ad1f5bfe
bibliographicCitation	Johnson BA, Baban B, Mellor AL. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy. 2009 Jul;1(4):645–61. PMID: 20161103; PMCID: PMC2746500.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cf809aa02f5d1890027e39ddf2596d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_758f26d53bda8d023e340b53acd3a41c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a9070e7249d0fbee59f9def6b68f575
date	200907
identifier	https://doi.org/10.2217/imt.09.21 https://pubmed.ncbi.nlm.nih.gov/20161103 https://pubmed.ncbi.nlm.nih.gov/PMC2746500
isPartOf	https://portal.issn.org/resource/ISSN/1750-7448 https://portal.issn.org/resource/ISSN/1750-743X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36319
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy
discusses	http://id.nlm.nih.gov/mesh/M0475654
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001327Q000276 http://id.nlm.nih.gov/mesh/D007167 http://id.nlm.nih.gov/mesh/D006967Q000276 http://id.nlm.nih.gov/mesh/D050503Q000378 http://id.nlm.nih.gov/mesh/D050378Q000276 http://id.nlm.nih.gov/mesh/D006084Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D050503Q000235 http://id.nlm.nih.gov/mesh/D024201 http://id.nlm.nih.gov/mesh/D007165 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D050503Q000276 http://id.nlm.nih.gov/mesh/D006084Q000628 http://id.nlm.nih.gov/mesh/D006967Q000628 http://id.nlm.nih.gov/mesh/D003713Q000378 http://id.nlm.nih.gov/mesh/D003713Q000276 http://id.nlm.nih.gov/mesh/D003713Q000473 http://id.nlm.nih.gov/mesh/D001327Q000628 http://id.nlm.nih.gov/mesh/D007249 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1aa5b90ebc4a2c73e845fc0f1a4ccc3b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.11.52 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129328711

Total number of triples: 67.